Renaissance BioScience Corp., a global leader in bioengineered yeast for the agriculture, food, environmental and energy industries, is pleased to announce the grant of another patent for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. Awarded by the Mexican patent office, this is the third patent issued for the company’s RNA technology following earlier grants in China and Australia, with additional jurisdictions pending. This new patent expands Renaissance’s robust IP portfolio of issued and pending patents for yeast-based technology patents across multiple end-use markets.Renaissance’s most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Equally importantly, the technology integrates smoothly into current farming practices and equipment.
Renaissance BioScience has received a new patent in Mexico for its yeast-based platform that enables low-cost RNA production and delivery, following earlier grants in China and Australia.
The technology underpins its advanced RNAi biopesticides, which offer targeted pest control with strong environmental safety.
The company says the platform also holds potential across multiple high-value markets.
Dr. John Husnik, Renaissance’s CSO and Office of the CEO, commented on the new patent: “This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets.”
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (RM)
marketing@alchempro.com
